FDA Drug Recalls

Recalls / Class II

Class IID-522-2013

Product

Maxifed DM, Expectorant, Nasal Decongestant, 100 count bottle, OTC, Manufactured for: MCR American Pharmaceuticals Inc. , Brooksville, FL 34604, NDC 58605-0409-01

Affected lot / code info
Lot# 11B002 Exp. 01/13; Lot# 11B003 Exp. 01/13; Lot # 11G007 Exp. 06/13; Lot# 11J002 Exp. 08/13; Lot# 11K002 Exp. 09/13; Lot# 12C011 Exp. 02/14.

Why it was recalled

CGMP Deviations: Products are underdosed or have an incorrect dosage regime.

Recalling firm

Firm
TG United, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
16275 Aviation Loop Dr, N/A, Brooksville, Florida 34604-6805

Distribution

Quantity
2706 bottles of 100 count tablets
Distribution pattern
FL, MS, SC, LA and TX

Timeline

Recall initiated
2013-01-30
FDA classified
2013-06-04
Posted by FDA
2013-06-12
Terminated
2016-09-30
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-522-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls